[1] 薛强.恶性胶质瘤术后同期推量调强放疗的疗效及其预后影响因素分析[J].东南大学学报(医学版),2016,35(5):746-751.
[2] 刘培党,金海振,赵静,等.纳米银联合辐射后脑胶质瘤细胞凋亡与小胶质细胞的变化及其关系[J].东南大学学报(医学版),2015,34(5):679-683.
[3] 罗起胜,黄海能,邓元央,等.慢病毒介导shRNA靶向ZNF217抑制胶质瘤细胞生长、迁移和侵袭[J].南方医科大学学报,2015,35(7):1024-1027.
[4] ZHANG H,NIE W,ZHANG X,et al.NEDD4-1 regulates migration and invasion of glioma cells through CNrasGEF ubiquitination in vitro[J].PLoS One,2013,8(12):e82789-e82799.
[5] PEI Z J,ZHANG Z G,HU A X,et al.miR-122-5p inhibits tumor cell proliferation and induces apoptosis by targeting MYC in gastric cancer cells[J].Pharmazie,2017,72(6):344-347.
[6] WAN Y,LI M,HUANG P.LINC01296 promotes proliferation,migration,and invasion of HCC cells by targeting miR-122-5P and modulating EMT activity[J].Onco Targets Ther,2019,12(1):2193-2203.
[7] TAI H,WU Z,SUN S,et al.FGFRL1 promotes ovarian cancer progression by crosstalk with hedgehog signaling[J].J Immunol Res,2018,2018(1):1-12.
[8] YANG X,SHI L,YI C,et al.MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1[J].Am J Cancer Res,2017,7(8):1738-1753.
[9] 徐然,仇文进,陈正新,等.FOXP2调控PI3K/Akt信号通路抑制胶质瘤的侵袭[J].南京医科大学学报(自然科学版),2017,37(5):559-563.
[10] 焦克平,赵玉梅,张晓敏.miR-425对胶质瘤细胞迁移与侵袭的影响[J].中国老年学杂志,2017,37(7):1615-1617.
[11] 张媛,沈云龙,崔玉婷,等.miRNA-374靶向PTTG基因抑制胶质瘤细胞的增殖和侵袭能力[J].中山大学学报(医学科学版),2017,38(4):498-504.
[12] 申松波,刘强,胡胜.miRNA-150在胶质瘤组织中的表达及对胶质瘤U87细胞增殖和侵袭能力的影响[J].山西医科大学学报,2018,49(12):1447-1451.
[13] 李璟蓉,赵瑞,方锐华,等.miR-122-5p通过靶向NOP14抑制黑素瘤的细胞增殖[J].南方医科大学学报,2018,38(11):1360-1365.
[14] 何佳,肖斌,杭建峰,等.血清miR-122-5p和miR-486-5p在肝癌诊断中的临床应用[J].中华检验医学杂志,2018,41(1):41-46.
[15] XU X,GAO F,WANG J,et al.MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4[J].Cancer Biol Ther,2018,19(5):427-435.
[16] LI Y,WANG H,HUANG H.Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer[J].Biochem Biophys Res Commun,2019,514(1):78-85.
[17] 刘志军,周海存,陈小兵,等.人脑胶质瘤组织中CPEB4的表达及与细胞迁移和侵袭的关系[J].郑州大学学报(医学版),2016,51(5):622-626.
[18] TAKEI Y,MATSUMURA T,WATANABE K,et al.FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from esophageal squamous cell carcinomas[J].Oncol Lett,2018,16(1):809-814.
[19] DI MARTINO E,TAYLOR C F,ROULSON J A,et al.An integrated genomic,transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer[J].Genes Chromosomes Cancer,2013,52(9):860-867.
[20] 张春,李清漪,董海影,等.PI3K/AKT/mTOR信号通路在诱导胶质瘤细胞凋亡中的作用[J].中国新药杂志,2016,25(16):1909-1912.
[21] 张振国,贾丽燕,杨廷舰,等.抑制PI3K/Akt信号通路对胶质瘤侵袭性及增殖力的影响[J/OL].中西医结合心血管病电子杂志,2018,6(7):183-185. |